Related Experiment Videos
A quantitative study of the pancuronium antagonism at the motor endplate in human organophosphorus intoxication
Abstract:
Nine patients with organophosphorus (OP) intoxication developing neuromuscular transmission defects were given pancuronium 1, 2, or 4 mg intravenously (IV). Thirteen patient controls with hypoxic encephalopathy received similar dosages. The responses were monitored electrophysiologically using single and repetitive nerve stimulation (20 and 50 Hz). In OP patients, pancuronium did not alter the amplitude of the single CMAP, whereas its repetitive discharges were reduced. Severe neuromuscular blocks were reversed only partially by pancuronium 4 mg. In less severe blocks, 1 and 2 mg resulted in marked improvement. In the patient controls, pancuronium 4 mg induced a severe neuromuscular block but not with 1 and 2 mg. Pancuronium dosages necessary to reverse severe OP-induced neuromuscular blockade produce a neuromuscular block when AChE activity is normal. Low dosages have little effect on normal neuromuscular transmission, but improve the block to a mild degree and may be useful as part of treatment in OP intoxications.
Insights
Pancuronium can partially reverse neuromuscular defects in organophosphorus (OP) intoxication. Low doses show promise for treating OP-induced blocks without significantly impacting normal nerve function.
Area of Science:
- Neurology
- Pharmacology
- Toxicology
Background:
- Organophosphorus (OP) intoxication can cause significant neuromuscular transmission defects.
- Understanding the effects of neuromuscular blocking agents in OP intoxication is crucial for patient management.
Purpose of the Study:
- To investigate the efficacy of pancuronium in reversing neuromuscular blockade in patients with OP intoxication.
- To compare the effects of pancuronium in OP-intoxicated patients versus patient controls with hypoxic encephalopathy.
Main Methods:
- Electrophysiological monitoring using single and repetitive nerve stimulation (20 and 50 Hz) in nine OP patients and thirteen controls.
- Intravenous administration of pancuronium at dosages of 1, 2, or 4 mg.
Main Results:
- Pancuronium did not alter single compound muscle action potential (CMAP) amplitude in OP patients but reduced repetitive discharges.
- High-dose pancuronium (4 mg) partially reversed severe OP-induced blocks, while lower doses (1-2 mg) improved less severe blocks.
- Pancuronium at 4 mg induced a severe neuromuscular block in controls, but not at lower doses.
Conclusions:
- Pancuronium dosages effective for severe OP-induced blockade can induce neuromuscular blockade in individuals with normal acetylcholinesterase (AChE) activity.
- Low-dose pancuronium may be beneficial in treating OP intoxications by mildly improving neuromuscular blockade with minimal effect on normal transmission.